New CEO commentary: “Understanding Skin Cancer”

August 13, 2018
Language flag

On the company’s webpage, PHI’s CEO and founder Peter Egelberg comments the latest research results by the scientists at the PHI/UCSF Holographic Imaging Cytometry Center of Excellence, see Commentary, “Understanding skin cancer”.

Latest News

PHI AB annual general meeting moved to 27 October 2023

The PHI AB board has decided to move the company’s annual general meeting from 12 October 2023 to 27 October 2023.
Businesspeople brainstorming together with sticky notes in an of

BioStock: PHI links up with two regenerative medicine networks

BioStock contacted CEO Patrik Eschricht to learn more about the company’s future strategies in regenerative medicine and the pivot toward the clinical market.
ARM-ATMP-banner-web

PHI Strengthens Commitment to Regenerative Medicine through ARM and ATMP Sweden Membership

PHI becomes a member of the leading international advocacy organization Alliance for Regenerative Medicine (ARM) as well as the national ATMP Sweden network to advocate for QPI technology for standard cell quality control in regenerative medicine.
See All News